Unknown

Dataset Information

0

Low incidence of pulmonary metastases in vulvar cancer patients: limited value of routine chest imaging based on a cohort study.


ABSTRACT:

Objective

To evaluate the incidence of pulmonary metastases in the preoperative work-up of patients with primary vulvar squamous cell carcinoma (SCC).

Design

Retrospective cohort study.

Setting

Tertiary referral centre.

Population

Patients treated for primary vulvar SCC from 2000 to 2018.

Methods

The pre-operative chest imaging of 452 consecutively treated patients was documented with a minimal follow-up period of 2 years.

Mean outcome measures

Incidence of pulmonary metastases, frequency of chest imaging and subsequent coincidental findings.

Results

In total, 80.8% of patients underwent pre-operative chest imaging. Seven patients (1.9%), with a median tumour size of 80 mm, presented with pulmonary metastases. None of the patients with early stage disease and tumour size <40 mm who underwent radical local excision (RLE) with sentinel node (SN)-procedure, was diagnosed with pulmonary metastasis. Chest imaging was performed by radiography (58.9%) and computerised tomography (CT) (41.1%). Coincidental findings were reported in 40.7% of patients who underwent CT, compared with 15.8% of patients undergoing radiography, resulting in additional diagnostics in 14.7 and 19.7% and being of limited consequence for outcome in 2.9 and 3.3%, respectively.

Conclusions

The incidence of pulmonary metastases in patients with primary vulvar SCC is extremely low, and none in patients with early stage disease undergoing the SN procedure. Chest imaging was performed in the majority of patients and was associated with frequent coincidental findings leading to clinically irrelevant diagnostic procedures. Therefore, we recommend omitting chest imaging in patients with early stage disease and tumours <40 mm, considering chest CT only in patients with large tumours and/or advanced stage disease.

Tweetable abstract

The incidence of pulmonary metastases is 1.9%, none in early stage disease planned for SN. Omitting chest imaging in this group is advised.

SUBMITTER: Pleunis N 

PROVIDER: S-EPMC9290465 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10491599 | biostudies-literature
| S-EPMC4449450 | biostudies-literature
| S-EPMC4419189 | biostudies-literature
| S-EPMC5857310 | biostudies-literature
| S-EPMC9651561 | biostudies-literature
| S-EPMC5820702 | biostudies-literature
| S-EPMC9166824 | biostudies-literature
| S-EPMC6799931 | biostudies-literature
| S-EPMC7082029 | biostudies-literature
| S-EPMC6668438 | biostudies-literature